Patent · US Expired

Method and apparatus for treatment of congestive heart failure by improving perfusion of the kidney by infusion of a vasodilator

US6287608A · kind A · utility

229Cited by
16References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 11, 2000
Grant dateSep 11, 2001
Priority date
Expiry dateApr 11, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K33/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for treating congestive heart failure (CHF) has been developed that restores kidney renal functions by artificial vasodilation of at least one kidney. A vasodilator drug is locally delivered to the kidney via a kidney perfusion catheter. The drug can be mixed with the patient's blood, saline or other suitable solvent and the mixture directly applied to the kidney through the catheter. The restoration of kidney function assists the heart by removing excess fluid, urine and toxin from the patient, and by normalizing the patient's renin-angiotensin system and other neurohormonal substances. The method is applicable to treat chronic and acute CHF.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.